Partners Demonstration Project

Phase:Demo Project
Principal Investigator(s):Led by a team of scientists from Kenya, Uganda and the US
Objective:Evaluates HIV prevention preferences among approximately 1,000 HIV serodiscordant couples, adherence to PrEP and ART and interface of reproductive health priorities and ART-based prevention. Will implement PrEP as “bridge” to ART, providing PrEP to HIV-negative partner when HIV-positive partner is not yet on ART due to ineligibility based on country guidelines or personal decision. **Preliminary results presented Feb 2015 show the use of PrEP reduced the risk of HIV infection by 96 percent.**
Prevention Option(s):PrEP
Study Design:
Trial Sponsors: Bill & Melinda Gates Foundation, NIMH/NIH, USAID
Start Date
End Date
August 31, 2013
December 31, 2016
Age range: 18 ↔ any
Population:Cisgender Men, Cisgender Women